Review: Higher vitamin D status and supplementation may be associated with risks

European Journal of Dermatology

Volumn 24, Issue 4, 2014, Pages 428-434

  Korgavkar, Kaveri ^a,b   Xiong, Michael ^a,b   Weinstock, Martin A ^a,b,c  

^a PROVIDENCE VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

Author keywords

Epidemiology; Vitamin D

Indexed keywords

CALCIFEDIOL; HEMOGLOBIN A1C; VITAMIN D; HYDROXYCOLECALCIFEROL; VITAMIN;

ACUTE CORONARY SYNDROME; ASTHMA; ATOPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FALLING; FRACTURE; HUMAN; META ANALYSIS (TOPIC); NEPHROLITHIASIS; PANCREAS CANCER; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SKIN CANCER; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADVERSE EFFECTS; BLOOD; CARDIOVASCULAR DISEASES; DIET SUPPLEMENTATION; FRACTURES, BONE; MORTALITY; NEOPLASMS; PRACTICE GUIDELINE; PREVALENCE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VITAMIN D DEFICIENCY;

ACCIDENTAL FALLS; ASTHMA; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FRACTURES, BONE; HUMANS; HYDROXYCHOLECALCIFEROLS; MORTALITY; NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 84922008522     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2014.2318     Document Type: Review

References (84)

1. Gilchrest BA. Sun protection and Vitamin D: three dimensions of obfuscation. J Steroid Biochem Mol Biol 2007; 103: 655-63.
2. Looker AC, Pfeiffer CM, Lacher DA, Schleicher RL, Picciano MF, Yetley EA. Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004. Am J Clin Nutr 2008; 88: 1519-27.
3. Gambichler T, Bindsteiner M, Hoxtermann S. Kreuter A. Serum 25-hydroxyvitamin D serum levels in a large German cohort of patients with melanoma. Br J Dermatol 2013; 168: 625-8.
4. Orgaz-Molina J, Magro-Checa C, Arrabal-Polo MA, et al. Association of 25-hydroxyvitamin D with Metabolic Syndrome in Patients with Psoriasis: A Case-control Study. Acta Derm Venereol 2013. doi: 10.2340/00015555-1642 (In press).
5. Orgaz-Molina J, Buendia-Eisman A, Arrabal-Polo MA, Ruiz JC, Arias-Santiago S. Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study. J Am Ac Dermatol 2012; 67: 931-8.
6. Gahche J, Bailey R, Burt V, et al. Dietary supplement use among U.S. adults has increased since NHANES III (1988-1994). NCHS Data Brief 2011; 61: 1-8.
7. Bailey RL, Dodd KW, Goldman JA, et al. Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010; 140: 817-22.
8. Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metabol 2011; 96: 53-8.
9. Institute of Medicine Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC.: The National Academies Press; 2011.
10. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for vitamin D. Am J Clin Nutr 2007; 85: 6-18.
11. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. New Engl J Med 2006; 354: 669-83.
12. Anaizi N. Rediscovering vitamin D. Libyan J Med 2010: 5.
13. Schottker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr 2013; 97: 782-93.
14. Scragg R. Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood. Public Health Nutr 2011; 14: 1515-32.
15. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Int Med 2008; 168: 1629-37.
16. Visser M, Deeg DJ, Puts MT, Seidell JC, Lips P. Low serum concentrations of 25-hydroxyvitamin D in older persons and the risk of nursing home admission. Am J Clin Nutr 2006; 84: 616-22 (quiz 71-2).
17. Jia X, Aucott LS, McNeill G. Nutritional status and subsequent allcause mortality in men and women aged 75 years or over living in the community. Br J Nutr 2007; 98: 593-9.
18. Michaelsson K, Baron JA, Snellman G, et al. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010; 92: 841-8.
19. Sempos CT, Durazo-Arvizu RA, Dawson-Hughes B, et al. Is there a Reverse J-shaped Association between 25-Hydroxyvitamin D and All-Cause Mortality? Results from the US Nationally Representative NHANES. J Clin Endocrinol Metabol 2013: 973001-9.
20. Dror Y, Giveon SM, Hoshen M, Feldhamer I, Balicer RD, Feldman BS. Vitamin d levels for preventing acute coronary syndrome and mortality: evidence of a nonlinear association. J Clin Endocrinol Metabol 2013; 98: 2160-7.
21. Durup D, Jorgensen HL, Christensen J, Schwarz P, Heegaard AM, Lind B. A reverse J-shaped association of all-cause mortality with serum 25-hydroxyvitamin D in general practice: the CopD study. J Clin Endocrinol Metabol 2012; 97: 2644-52.
22. Langsetmo L, Berger C, Kreiger N, et al. Calcium and Vitamin D Intake and Mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metabol 2013; 98: 3010-8.
23. Krause R, Schober-Halstenberg HJ, Edenharter G, Haas K, Roth HJ, Frei U. Vitamin D status and mortality of German hemodialysis patients. Anticancer Res 2012; 32: 391-5.
24. Cawthon PM, Parimi N, Barrett-Connor E, et al. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metabol 2010; 95: 4625-34.
25. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI. Serum 25-hydroxyvitamin D and cancer mortality in the NHANES III study (1988-2006). Cancer Res 2010; 70: 8587-97.
26. Pilz S, Kienreich K, Tomaschitz A, et al. Vitamin d and cancer mortality: systematic review of prospective epidemiological studies. Anticancer Agents Med Chem 2013; 13: 107-17.
27. Klein EA, Thompson IM Jr., Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA: J Am Medical Assoc 2011; 306: 1549-56.
28. Albanes D, Heinonen OP, Huttunen JK, et al. Effects of alphatocopherol and beta-carotene supplements on cancer incidence in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 1995; 62: 1427S-30S.
29. Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Nat Cancer Inst 2006; 98: 451-9.
30. Ordonez Mena JM, Schottker B, Haug U, et al. Serum 25-hydroxyvitamin D and cancer risk in older adults. Results from a large German prospective cohort study. Cancer Epidemiol Biomarkers Prev 2013; 22: 905-16.
31. Giovannucci E, Liu Y, Willett WC. Cancer incidence and mortality and vitamin D in black and white male health professionals. Cancer Epidemiol, biomarkers & prevention 2006; 15: 2467-72.
32. Skinner HG, Michaud DS, Giovannucci E, Willett WC, Colditz GA, Fuchs CS. Vitamin D intake and the risk for pancreatic cancer in two cohort studies. Cancer Epidemiol Biomarkers Prev 2006; 15: 1688-95.
33. Wolpin BM, Ng K, Bao Y, et al. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2012; 21: 82-91.
34. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA, et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol 2010; 172: 81-93.
35. Stolzenberg-Solomon RZ, Vieth R, Azad A, et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 2006; 66: 10213-9.
36. Weinstein SJ, Stolzenberg-Solomon RZ, Kopp W, Rager H, Virtamo J, Albanes D. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study. Cancer Res 2012; 72: 1190-8.
37. Helzlsouer KJ, Gallicchio L. Shedding light on serum vitamin d concentrations and the risk of rarer cancers. Anticancer Agents Med Chem 2013; 13: 65-9.
38. Tuohimaa P, Tenkanen L, Ahonen M, et al. Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: a longitudinal, nested case-control study in the Nordic countries. Int J Cancer 2004; 108: 104-8.
39. Brandstedt J, Almquist M, Manjer J, Malm J, Vitamin D. PTH, and calcium and the risk of prostate cancer: a prospective nested casecontrol study. Cancer Causes Control: CCC 2012; 23: 1377-85.
40. Meyer HE, Robsahm TE, Bjorge T, Brustad M, Blomhoff R. Vitamin D, season, and risk of prostate cancer: a nested case-control study within Norwegian health studies. Am J Clin Nutr 2013; 97: 147-54.
41. Albanes D, Mondul AM, Yu K, et al. Serum 25-hydroxy vitamin D and prostate cancer risk in a large nested case-control study. Cancer Epidemiol Biomarkers Prev 2011; 20: 1850-60.
42. Gandini S, Boniol M, Haukka J, et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 2011; 128: 1414-24.
43. van der Pols JC, Russell A, Bauer U, Neale RE, Kimlin MG, Green AC. Vitamin d status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community. J Invest Dermatol 2013; 133: 637-41.
44. Afzal S, Nordestgaard BG, Bojesen SE. Plasma 25-hydroxyvitamin d and risk of non-melanoma and melanoma skin cancer: a prospective cohort study. J Invest Dermatol 2013; 133: 629-36.
45. Liang G, Nan H, Qureshi AA, Han J. Pre-diagnostic plasma 25-hydroxyvitamin D levels and risk of non-melanoma skin cancer in women. PloS one 2012; 7: e35211.
46. Asgari MM, Tang J, Warton ME, et al. Association of prediagnostic serum vitamin D levels with the development of basal cell carcinoma. J Invest Dermatol 2010; 130: 1438-43.
47. Asgari MM, Maruti SS, Kushi LH, White E. A cohort study of vitamin D intake and melanoma risk. J Invest Dermatol 2009; 129: 1675-80.
48. Tang JY, Fu T, Leblanc E, et al. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women’s health initiative randomized controlled trial. J Clin Oncol 2011; 29: 3078-84.
49. Reddy KK. Vitamin d level and Basal cell carcinoma, squamous cell carcinoma, and melanoma risk. J Invest Dermatol 2013; 133: 589-92.
50. Brondum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler Thromb Vasc Biol 2012; 32: 2794-802.
51. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503-11.
52. Linden V. Vitamin D and myocardial infarction. Br Med J 1974; 3: 647-50.
53. Alele JD, Luttrell LM, Hollis BW, Luttrell DK, Hunt KJ. Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis 2013; 228: 502-7.
54. Rajasree S, Rajpal K, Kartha CC, et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heartdisease. Eur J Epidemiol 2001; 17: 567-71.
55. Smith M. Vitamin D Excess Is Significantly Associated with Risk of Atrial Fibrillation. In: American Heart Association Meeting; 2011, 2011.
56. Freedman BI, Wagenknecht LE, Hairston KG, et al. Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metabol 2010; 95: 1076-83.
57. Shroff R, Egerton M, Bridel M, et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008; 19: 1239-46.
58. Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 2012; 11: 42.
59. Heikkinen AM, Tuppurainen MT, Niskanen L, Komulainen M, Penttila I, Saarikoski S. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrin 1997; 137: 495-502.
60. Tuppurainen M, Heikkinen AM, Penttila I, Saarikoski S. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. Maturitas 1995; 22: 55-61.
61. Jorde R, Strand Hutchinson M, Kjaergaard M, Sneve M, Grimnes G. Supplementation with High Doses of Vitamin D to Subjects without Vitamin D Deficiency May Have Negative Effects: Pooled Data from Four Intervention Trials in Tromso. ISRN Endocrin 2013; 2013: 348705.
62. Sanders KM, Stuart AL, Williamson EJ, et al. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 2010; 303: 1815-22.
63. Smith H, Anderson F, Raphael H, Maslin P, Crozier S, Cooper C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women-a population-based, randomized, double-blind, placebocontrolled trial. Rheumatology 2007; 46: 1852-7.
64. Minisola S, Colangelo L, Cilli M, Cipriani C, Pepe J, Romagnoli E. Intermittent high doses of vitamin d: a need for further studies? Calcif Tissue Int 2013; 92: 487-8.
65. Sanders KM, Nicholson GC, Ebeling PR. Is high-dose vitamin d harmful? Authors’ reply. Calcif Tissue Int 2013; 92: 491-2.
66. Sanders KM, Nicholson GC, Ebeling PR. Is high dose vitamin D harmful? Calcif Tissue Int 2013; 92: 191-206.
67. Eisner BH, Thavaseelan S, Sheth S, Haleblian G, Pareek G. Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis. Urology 2012; 80: 1007-10.
68. Netelenbos JC, Jongen MJ, van der Vijgh WJ, Lips P, van Ginkel FC. Vitamin D status in urinary calcium stone formation. Arch Int Med 1985; 145: 681-4.
69. Fallahzadeh MH, Zare J, Al-Hashemi GH, et al. Elevated serum levels of Vitamin D in infants with urolithiasis. Iranian J Kidney Dis 2012; 6: 186-91.
70. Tang J, McFann KK, Chonchol MB. Association between serum 25-hydroxyvitamin D and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988-94. Nephrol Dialysis Transplant 2012; 27: 4385-9.
71. Xu L, Wan X, Huang Z, et al. Impact of vitamin d on chronic kidney diseases in non-dialysis patients: a meta-analysis of randomized controlled trials. PloS one 2013; 8: e61387.
72. Cranney A, Horsley T, O’Donnell S, et al. Effectiveness and safety of vitamin D in relation to bone health. Evid Rep Technol Assess (Full Rep) 2007: 1-235.
73. Keet CA, McCormack MC, Peng RD, Matsui EC. Age-and atopydependent effects of vitamin D on wheeze and asthma. J Allergy Clin Immunol 2011; 128: 414-6, e5.
74. Mai XM, Langhammer A, Camargo CA Jr., Chen Y. Serum 25-hydroxyvitamin D levels and incident asthma in adults: the HUNT Study. Am J Epidemiol 2012; 176: 1169-76.
75. Hypponen E, Sovio U, Wjst M, et al. Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann New York Acad Sci 2004; 1037: 84-95.
76. Back O, Blomquist HK, Hernell O, Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol 2009; 89: 28-32.
77. Hollams EM, Hart PH, Holt BJ, et al. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Resp J 2011; 38: 1320-7.
78. Gale CR, Robinson SM, Harvey NC, et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr 2008; 62: 68-77.
79. Pike KC, Inskip HM, Robinson S, et al. Maternal late-pregnancy serum 25-hydroxyvitamin D in relation to childhood wheeze and atopic outcomes. Thorax 2012; 67: 950-6.
80. Miyake Y, Sasaki S, Tanaka K, Hirota Y. Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur Resp J 2010; 35: 1228-34.
81. Selby PL, Davies M, Marks JS, Mawer EB. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate. Clin Endocrin 1995; 43: 531-6.
82. Sage RJ, Rao DS, Burke RR, Lim HW. Preventing vitamin D toxicity in patients with sarcoidosis. J Am Ac Dermatol 2011; 64: 795-6.
83. Brannon PM, Yetley EA, Bailey RL, Picciano MF. Overview of the conference “Vitamin D and Health in the 21st Century: an Update”. Am J Clin Nutr 2008; 88: 483S-90S.
84. Weinstock MA, Moses AM. Skin cancer meets vitamin D: the way forward for dermatology and public health. J Am Ac Dermatol 2009; 61: 720-4.